Xanthoma, xanthelasma, it’s all Greek to me – lipid management in diabetes is more than skin deep…

May journal club
Current Status
Not Enrolled
Price
ZAR 92.00
Get Started

Integral to the management of type 2 diabetes is ensuring that the attendant blood lipid abnormalities are optimally treated.

Guidelines abound setting out specific targets for these lipid sub-fractions, yet clinical trials and real-world data consistently document the failure to achieve these numeric endpoints. Because cardiovascular conditions such as atherosclerotic heart disease and stroke remain the leading cause of death in people with diabetes, reversing this apparent clinical inertia is mandatory. Decades worth of published trials confirm the fundamental place of statins in the treatment paradigm. What then is the role of non-statin treatments?

Current Status
Not Enrolled
Price
ZAR 92.00
Get Started

welcome to
CDE ACADEMY

CDE ACADEMY

Login to your account

Course Content

Current Status
Not Enrolled
Price
ZAR 92.00
Get Started

Welcome to the CDE Academy

Course Content

Current Status
Not Enrolled
Price
ZAR 92.00
Get Started

Subscribe to our

Newsletters

(Please note that subscribing here does NOT register you for any CDE Course)

Course Content